The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
Published: 2 February 2026
A promising new scanning agent developed by researchers at the universities of Glasgow and Edinburgh has proved suitable for further testing in humans, opening the way for further clinical exploration. The first whole body in-vivo analysis has shown the Positron Emission Tomography (PET) radiotracer LW223 is safe and tolerable in healthy humans.